A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using...

Por Julka, P K, Chacko, R T, Nag, S, Parshad, R, Nair, A, Oh, D S, Hu, Z, Koppiker, C B, Nair, S, Dawar, R, Dhindsa, N, Miller, I D, Ma, D, Lin, B, Awasthy, B, Perou, C M
Publicado em 2008

PD-023 Safety across subgroups in NAPOLI-1: a phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) prev...

Por Chen, L.-T., Siveke, J., Wang-Gillam, A., Hubner, R., Pant, S., Dragovich, T., Chung, V., Chang, D., Ross, P., Cooray, P., Tebbutt, N., Franke, F., Belanger, B., Dhindsa, N., de Jong, F., Mamlouk, K., Von Hoff, D.
Publicado no Ann Oncol (2016)